Cyclacel Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Cyclacel Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.18M, a 68.2% increase year-over-year.
  • Cyclacel Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$15.5M, a 46.3% increase year-over-year.
  • Cyclacel Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$25.5M, a 7.97% increase from 2022.
  • Cyclacel Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$27.7M, a 23.5% decline from 2021.
  • Cyclacel Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$22.4M, a 111% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$15.5M -$2.18M +$4.67M +68.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$20.2M -$3.64M +$2.29M +38.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$22.5M -$4.36M +$2.96M +40.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$25.5M -$5.36M +$3.49M +39.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$28.9M -$6.85M -$378K -5.85% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$28.6M -$5.93M -$144K -2.49% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$28.4M -$7.32M -$760K -11.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$27.7M -$8.85M -$2.57M -40.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$25.1M -$6.47M -$763K -13.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-29
Q2 2022 -$24.3M -$5.79M +$315K +5.16% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$24.6M -$6.56M -$2.25M -52.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$22.4M -$6.28M -$3.11M -98.2% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-11-29
Q3 2021 -$19.3M -$5.7M -$3.13M -122% Jul 1, 2021 Sep 30, 2021 10-K/A 2023-11-29
Q2 2021 -$16.1M -$6.1M -$3.63M -147% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$12.5M -$4.31M -$1.88M -77.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$10.6M -$3.17M -$375K -13.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$10.3M -$2.57M -$224K -9.54% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$10M -$2.47M -$135K -5.78% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$9.9M -$2.42M -$220K -9.98% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$9.68M -$2.79M -$327K -13.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$9.36M -$2.35M +$107K +4.36% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$9.46M -$2.34M +$128K +5.19% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$9.59M -$2.2M -$42K -1.94% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 -$9.55M -$2.47M -$269K -12.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$9.28M -$2.46M -$343K -16.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$8.94M -$2.47M +$24K +0.96% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$8.96M -$2.16M +$531K +19.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$9.49M -$2.2M +$972K +30.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 -$10.5M -$2.11M +$1.37M +39.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$11.8M -$2.49M +$1.27M +33.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$13.1M -$2.69M +$1.05M +28.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$14.2M -$3.17M +$692K +17.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 -$14.8M -$3.48M -$83K -2.45% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$14.8M -$3.76M -$143K -3.95% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$14.6M -$3.74M +$1.55M +29.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$16.2M -$3.86M +$1.92M +33.2% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$18.1M -$3.39M +$2.28M +40.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$20.4M -$3.62M +$1.96M +35.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$22.3M -$5.3M +$112K +2.07% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$22.4M -$5.78M -$1.81M -45.5% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-29
Q3 2014 -$20.6M -$5.67M +$125K +2.16% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$20.8M -$5.58M -$1.42M -34.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 -$19.3M -$5.41M -$1.36M -33.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 -$18M -$3.97M +$680K +14.6% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$18.7M -$5.8M -$2.27M -64.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$16.4M -$4.15M -$342K -8.97% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$16M -$4.05M -$936K -30% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 -$15.1M -$4.65M -$1.38M -42.3% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-26
Q3 2012 -$13.7M -$3.52M +$358K +9.23% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$14.1M -$3.81M -$15K -0.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$14.1M -$3.12M +$1.69M +35.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q4 2011 -$15.7M -$3.27M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-26
Q3 2011 -$3.88M +$118K +2.95% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-16
Q2 2011 -$3.8M +$589K +13.4% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$4.8M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$4M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$4.39M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.